Phase 1 Clinical Study With DAS181: Double-Blind, Randomized, Placebo-Controlled, Single Dose Escalation Study in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2013
At a glance
- Drugs DAS 181 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors NexBio
- 04 Feb 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 04 Feb 2010 Actual patient number (45) added as reported by ClinicalTrials.gov.
- 04 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.